HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miriam Caramanti Selected Research

Anemia

3/2016Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Miriam Caramanti Research Topics

Disease

11Neoplasms (Cancer)
03/2024 - 01/2013
4Hyponatremia
06/2020 - 06/2016
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019 - 01/2013
3Breast Neoplasms (Breast Cancer)
03/2024 - 03/2013
2Thymoma (Thymic Carcinoma)
01/2020 - 08/2015
2Thymus Neoplasms (Thymus Neoplasm)
08/2015 - 05/2014
2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2010 - 01/2010
1Hypoxia (Hypoxemia)
12/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
06/2020
1Inflammation (Inflammations)
10/2019
1Inappropriate ADH Syndrome (SIADH)
01/2019
1Lung Neoplasms (Lung Cancer)
04/2017
1Adenocarcinoma of Lung
12/2016
1Lymphopenia (Lymphocytopenia)
05/2016
1Anemia
03/2016
1Malignant Mesothelioma
03/2016
1Embryonal Carcinoma
01/2015
1Brain Neoplasms (Brain Tumor)
01/2015
1Triple Negative Breast Neoplasms
06/2014
1Carcinogenesis
05/2014
1Heart Failure
10/2013
1Acute Coronary Syndrome
10/2013
1Cardiotoxicity
10/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2013
1Ovarian Neoplasms (Ovarian Cancer)
03/2013
1Neoplasm Metastasis (Metastasis)
03/2013
1Circulating Neoplastic Cells
03/2013
1Melanoma (Melanoma, Malignant)
03/2013
1Thyroid Neoplasms (Thyroid Cancer)
03/2013
1Cardiovascular Diseases (Cardiovascular Disease)
01/2010

Drug/Important Bio-Agent (IBA)

3SodiumIBA
06/2020 - 04/2017
2eribulinFDA Link
03/2024 - 01/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 08/2015
2ParaffinIBA
01/2020 - 08/2015
2Hormones (Hormone)IBA
01/2019 - 06/2016
2DiureticsIBA
01/2019 - 06/2016
2Vasopressins (Vasopressin)IBA
01/2019 - 06/2016
2Endothelin-1 (Endothelin 1)IBA
07/2010 - 01/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2010 - 01/2010
2GhrelinIBA
07/2010 - 01/2010
1RNA (Ribonucleic Acid)IBA
03/2024
1Paclitaxel (Taxol)FDA LinkGeneric
03/2024
1Pemetrexed (MTA)FDA Link
03/2024
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2020
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2020
1Tumor Biomarkers (Tumor Markers)IBA
06/2020
1AntigensIBA
06/2020
1CarbohydratesIBA
06/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2020
1B7-H1 AntigenIBA
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1Programmed Cell Death 1 ReceptorIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1TolvaptanFDA Link
01/2019
1AndrogensIBA
12/2016
1Estrogens (Estrogen)FDA Link
12/2016
1ProgesteroneFDA LinkGeneric
12/2016
1ElectrolytesIBA
06/2016
1AsbestosIBA
03/2016
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2016
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
08/2015
1DNA (Deoxyribonucleic Acid)IBA
08/2015
1ChromiumIBA
01/2015
1Androgen Receptors (Androgen Receptor)IBA
06/2014
1SERPIN-B5 (maspin)IBA
03/2013
1Transcription Factors (Transcription Factor)IBA
03/2013
1Tyrosine Kinase InhibitorsIBA
01/2013
1Gefitinib (Iressa)FDA Link
01/2013
1ErbB Receptors (EGF Receptor)IBA
01/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2013

Therapy/Procedure

10Therapeutics
06/2020 - 03/2013
6Drug Therapy (Chemotherapy)
12/2016 - 10/2013
1Biological Therapy
01/2016
1Thymectomy
08/2015
1Aftercare (After-Treatment)
10/2013